Abstract
Trigeminal inflammatory pain is one of the most severe pain-related disorders in humans; however, the underlying mechanisms remain largely unknown. In this study, we investigated the possible contribution of interaction between ten-eleven translocation methylcytosine dioxygenase 1 (TET1) and the voltage-gated K+ channel Kv7.2 (encoded by Kcnq2) to orofacial inflammatory pain in mice. We found that complete Freund’s adjuvant (CFA) injection reduced the expression of Kcnq2/Kv7.2 in the trigeminal ganglion (TG) and induced orofacial inflammatory pain. The involvement of Kv7.2 in CFA-induced orofacial pain was further confirmed by Kv7.2 knockdown or overexpression. Moreover, TET1 knockdown in Tet1flox/flox mice significantly reduced the expression of Kv7.2 and M currents in the TG and led to pain-like behaviors. Conversely, TET1 overexpression by lentivirus rescued the CFA-induced decreases of Kcnq2 and M currents and alleviated mechanical allodynia. Our data suggest that TET1 is implicated in CFA-induced trigeminal inflammatory pain by positively regulating Kv7.2 in TG neurons.
Similar content being viewed by others
References
Horst OV, Cunha-Cruz J, Zhou L, Manning W, Mancl L, DeRouen TA. Prevalence of pain in the orofacial regions in patients visiting general dentists in the Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry research network. J Am Dent Assoc 2015, 146: 721–728.e3.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013, 33: 629–808.
Aczél T, Kecskés A, Kun J, Szenthe K, Bánáti F, Szathmary S. Hemokinin-1 gene expression is upregulated in trigeminal Ganglia in an inflammatory orofacial pain model: Potential role in peripheral sensitization. Int J Mol Sci 2020, 21: E2938.
Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288: 1765–1769.
Kuner R. Central mechanisms of pathological pain. Nat Med 2010, 16: 1258–1266.
Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998, 282: 1890–1893.
Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998, 18: 25–29.
Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279: 403–406.
Linley JE, Rose K, Patil M, Robertson B, Akopian AN, Gamper N. Inhibition of M current in sensory neurons by exogenous proteases: A signaling pathway mediating inflammatory nociception. J Neurosci 2008, 28: 11240–11249.
Liu B, Linley JE, Du X, Zhang X, Ooi L, Zhang H, et al. The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl- channels. J Clin Invest 2010, 120: 1240–1252.
Rose K, Ooi L, Dalle C, Robertson B, Wood IC, Gamper N. Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain 2011, 152: 742–754.
Djouhri L, Zeidan A, Abd El-Aleem SA. Changes in expression of Kv7.5 and Kv7.2 channels in dorsal root ganglion neurons in the streptozotocin rat model of painful diabetic neuropathy. Neurosci Lett 2020, 736: 135277.
Poetsch AR, Plass C. Transcriptional regulation by DNA methylation. Cancer Treat Rev 2011, 37: S8-12.
Hsieh MC, Ho YC, Lai CY, Chou D, Wang HH, Chen GD, et al. Melatonin impedes Tet1-dependent mGluR5 promoter demethylation to relieve pain. J Pineal Res 2017, https://doi.org/10.1111/jpi.12436.
Wu Q, Wei G, Ji F, Jia S, Wu S, Guo X, et al. TET1 overexpression mitigates neuropathic pain through rescuing the expression of μ-opioid receptor and Kv1.2 in the primary sensory neurons. Neurotherapeutics 2019, 16: 491–504.
Jia S, Wei G, Bono J, Pan Z, Zheng B, Wang B, et al. TET1 overexpression attenuates paclitaxel-induced neuropathic pain through rescuing K2p1.1 expression in primary sensory neurons of male rats. Life Sci 2022, 297: 120486.
Pan Z, Zhang M, Ma T, Xue ZY, Li GF, Hao LY, et al. Hydroxymethylation of microRNA-365-3p regulates nociceptive behaviors via Kcnh2. J Neurosci 2016, 36: 2769–2781.
Zhang Y, Chen Y, Liedtke W, Wang F. Lack of evidence for ectopic sprouting of genetically labeled Aβ touch afferents in inflammatory and neuropathic trigeminal pain. Mol Pain 2015, 11: 18.
Cui WQ, Zhang WW, Chen T, Li Q, Xu F, Mao-Ying QL, et al. Tacr3 in the lateral habenula differentially regulates orofacial allodynia and anxiety-like behaviors in a mouse model of trigeminal neuralgia. Acta Neuropathol Commun 2020, 8: 44.
Wang S, Bian C, Yang J, Arora V, Gao Y, Wei F, et al. Ablation of TRPV1+ afferent terminals by capsaicin mediates long-lasting analgesia for trigeminal neuropathic pain. eNeuro 2020, https://doi.org/10.1523/ENEURO.0118-20.2020.
Kim YS, Chu Y, Han L, Li M, Li Z, LaVinka PC, et al. Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain. Neuron 2014, 81: 873–887.
Ju YY, Jiang M, Xu F, Wang D, Ding B, Ma LJ, et al. CXCL10 and CXCR3 in the trigeminal ganglion contribute to trigeminal neuropathic pain in mice. J Pain Res 2021, 14: 41–51.
Neubert JK, Mannes AJ, Keller J, Wexel M, Iadarola MJ, Caudle RM. Peripheral targeting of the trigeminal ganglion via the infraorbital foramen as a therapeutic strategy. Brain Res Brain Res Protoc 2005, 15: 119–126.
Laumet G, Garriga J, Chen SR, Zhang Y, Li DP, Smith TM, et al. G9a is essential for epigenetic silencing of K(+) channel genes in acute-to-chronic pain transition. Nat Neurosci 2015, 18: 1746–1755.
Crozier RA, Ajit SK, Kaftan EJ, Pausch MH. MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J Neurosci 2007, 27: 4492–4496.
Zheng Q, Fang D, Liu M, Cai J, Wan Y, Han JS, et al. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model. Pain 2013, 154: 434–448.
Xu W, Wu Y, Bi Y, Tan L, Gan Y, Wang K. Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats. Mol Pain 2010, 6: 1744–8069.
Teng BC, Song Y, Zhang F, Ma TY, Qi JL, Zhang HL, et al. Activation of neuronal Kv7/KCNQ/M-channels by the opener QO58-lysine and its anti-nociceptive effects on inflammatory pain in rodents. Acta Pharmacol Sin 2016, 37: 1054–1062.
Liu Y, Bian X, Wang K. Pharmacological activation of neuronal voltage-gated Kv7/KCNQ/M-channels for potential therapy of epilepsy and pain. Handb Exp Pharmacol 2021, 267: 231–251.
Abd-Elsayed A, Jackson M, Gu SL, Fiala K, Gu J. Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain. Mol Pain 2019, 15: 1744806919864256.
Wang J, Liu Y, Hu F, Yang J, Guo X, Hou X, et al. Activation of neuronal voltage-gated potassium Kv7/KCNQ/M-current by a novel channel opener SCR2682 for alleviation of chronic pain. J Pharmacol Exp Ther 2021, 377: 20–28.
Zhang F, Liu S, Jin L, Tang L, Zhao X, Yang T, et al. Antinociceptive efficacy of retigabine and flupirtine for gout arthritis pain. Pharmacology 2020, 105: 471–476.
Li H, Wang F, Wang X, Sun R, Chen J, Chen B, et al. Antinociceptive efficacy of retigabine in the monosodium lodoacetate rat model for osteoarthritis pain. Pharmacology 2015, 95: 251–257.
Cai J, Fang D, Liu XD, Li S, Ren J, Xing GG. Suppression of KCNQ/M (Kv7) potassium channels in the spinal cord contributes to the sensitization of dorsal horn WDR neurons and pain hypersensitivity in a rat model of bone cancer pain. Oncol Rep 2015, 33: 1540–1550.
Li L, Li J, Zuo Y, Dang D, Frost JA, Yang Q. Activation of KCNQ channels prevents paclitaxel-induced peripheral neuropathy and associated neuropathic pain. J Pain 2019, 20: 528–539.
Peiris M, Hockley JR, Reed DE, Smith ESJ, Bulmer DC, Blackshaw LA. Peripheral KV7 channels regulate visceral sensory function in mouse and human colon. Mol Pain 2017, 13: 1744806917709371.
Djouhri L, Malki MI, Zeidan A, Nagi K, Smith T. Activation of Kv7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy. J Drug Target 2019, 27: 1118–1126.
Wu YJ, Conway CM, Sun LQ, Machet F, Chen J, Chen P, et al. Discovery of (S, E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain. Bioorg Med Chem Lett 2013, 23: 6188–6191.
Surur AS, Bock C, Beirow K, Wurm K, Schulig L, Kindermann MK, et al. Flupirtine and retigabine as templates for ligand-based drug design of KV7.2/3 activators. Org Biomol Chem 2019, 17: 4512–4522.
Mucha M, Ooi L, Linley JE, Mordaka P, Dalle C, Robertson B, et al. Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability. J Neurosci 2010, 30: 13235–13245.
Zhang F, Mi Y, Qi JL, Li JW, Si M, Guan BC, et al. Modulation of K(v)7 potassium channels by a novel opener pyrazolo[1, 5-a]pyrimidin-7(4H)-one compound QO-58. Br J Pharmacol 2013, 168: 1030–1042.
Kanyo R, Wang CK, Locskai LF, Li J, Allison WT, Kurata HT. Functional and behavioral signatures of Kv7 activator drug subtypes. Epilepsia 2020, 61: 1678–1690.
Lai CY, Hsieh MC, Yeh CM, Yang PS, Cheng JK, Wang HH, et al. MicroRNA-489-3p attenuates neuropathic allodynia by regulating oncoprotein DEK/TET1-dependent epigenetic modification in the dorsal horn. Neuropharmacology 2022, 210: 109028.
Pan Z, Zhang Q, Liu X, Zhou H, Jin T, Hao LY, et al. Methyltransferase-like 3 contributes to inflammatory pain by targeting TET1 in YTHDF2-dependent manner. Pain 2021, 162: 1960–1976.
Deng J, Ding HH, Long JL, Lin SY, Liu M, Zhang XQ, et al. Oxaliplatin-induced neuropathic pain involves HOXA6 via a TET1-dependent demethylation of the SOX10 promoter. Int J Cancer 2020, 147: 2503–2514.
Yu H, Wu M, Townsend SD, Zou B, Long S, Daniels JS, et al. Discovery, synthesis, and structure activity relationship of a series of N-aryl-bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a novel KCNQ2 and KCNQ4 potassium channel opener. ACS Chem Neurosci 2011, 2: 572–577.
Kharkovets T, Hardelin JP, Safieddine S, Schweizer M, El-Amraoui A, Petit C, et al. KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci U S A 2000, 97: 4333–4338.
Acknowledgments
We would like to thank Dr. Guoliang Xu (Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, China) for the gift of the Tet1flox/flox mice. This work was supported by the National Natural Science Foundation of China (81771195 and 81971061), and the Program for Innovative Research Team in Universities of Henan Province (22IRTSTHN028).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors claim that there are no conflicts of interest.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhan, D., Zhang, J., Su, S. et al. TET1 Participates in Complete Freund’s Adjuvant-induced Trigeminal Inflammatory Pain by Regulating Kv7.2 in a Mouse Model. Neurosci. Bull. (2023). https://doi.org/10.1007/s12264-023-01139-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12264-023-01139-1